The scientists who tackled Covid are now looking to find treatments for severe flu as fears grow there could be a record number of cases this winter.
A new clinical trial will use lessons learned from the pandemic to help quickly find treatments for severe flu, as experts warn there could be record numbers of cases this year.There is no clear evidence about which treatments are best for severe cases.
The nature of the trial will allow the team to ensure people are given treatments that show encouraging results as soon as possible. These include the anti-viral treatments oseltamivir and baloxavir, as well as steroids and anti-inflammatory drugs that were found to be effective against Covid. ‘Getting the free spray flu vaccine is our first line of defence and drastically reduces the risks for children. But we also need more treatments to help those children who do become very ill, which is why this trial is so important.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery - Molecular BiomedicinePeople with acute COVID-19 due to SARS-CoV-2 infection experience a range of symptoms, but major factors contributing to severe clinical outcomes remain to be understood. Emerging evidence suggests associations between the gut microbiome and the severity and progression of COVID-19. To better understand the host-microbiota interactions in acute COVID-19, we characterized the intestinal microbiome of patients with active SARS-CoV-2 infection in comparison to recovered patients and uninfected healthy controls. We performed 16S rRNA sequencing of stool samples collected between May 2020 and January 2021 from 20 COVID-19-positive patients, 20 COVID-19-recovered subjects and 20 healthy controls. COVID-19-positive patients had altered microbiome community characteristics compared to the recovered and control subjects, as assessed by both α- and β-diversity differences. In COVID-19-positive patients, we observed depletion of Bacteroidaceae, Ruminococcaceae, and Lachnospiraceae, as well as decreased relative abundances of the genera Faecalibacterium, Adlercreutzia, and the Eubacterium brachy group. The enrichment of Prevotellaceae with COVID-19 infection continued after viral clearance; antibiotic use induced further gut microbiota perturbations in COVID-19-positive patients. In conclusion, we present evidence that acute COVID-19 induces gut microbiota dysbiosis with depletion of particular populations of commensal bacteria, a phenomenon heightened by antibiotic exposure, but the general effects do not persist post-recovery.
Read more »
Clinical trial: Blood thinning drug to treat recovery from severe COVID-19 is not effectiveA drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a U.K.-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.
Read more »
Xi Jinping’s ‘myth of infallibility’ tested as zero-Covid protests rattle China\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Read more »
China COVID crisis prompts sharp falls in oil and stock marketsFinancial analysts say that growing public protests could be the catalyst for a Chinese plan to live with COVID but, for now, the focus is on the damage being inflicted on the economy.
Read more »
BBC journalist arrested covering China protestsEd Lawrence was detained by police covering protests against China's zero-Covid policy.
Read more »